EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats

Antonio González-Ruiz, Silvia Flaj, Víctor Fernández-Cabello, Ernesto Quesada, Visitación López-Miranda, Esperanza Herradón

International Immunopharmacology · 2026-08 · 183 · 116884

DOI: 10.1016/j.intimp.2026.116884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-08. Verfasst von Antonio González-Ruiz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. Atenas s/n 28922 Alcorcón, Madrid,…. Hauptthemen laut MEDLINE: Cisplatin, Toll-Like Receptor 4, Antineoplastic Agents, Cardiotoxicity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: H2020 European Research Council, Community of Madrid Department of Education Science and Universities, State Agency of Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinToll-Like Receptor 4Antineoplastic AgentsCardiotoxicityAnimalsMaleRats, WistarNLR Family, Pyrin Domain-Containing 3 ProteinRatsMyeloid Differentiation Factor 88KidneyOxidative StressHeartSignal TransductionInterleukin-18

Stichwörter der Autor:innen

Cardiovascular toxicityCisplatinRenal injuryTLR4 blockade

Substanzen

CisplatinToll-Like Receptor 4NLR Family, Pyrin Domain-Containing 3 ProteinTlr4 protein, ratMyeloid Differentiation Factor 88Antineoplastic AgentsNlrp3 protein, ratMyd88 protein, ratInterleukin-18

Autor:innen und Institutionen

  • Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. Atenas s/n 28922 Alcorcón, Madrid, Spain; High Performance Research Group in Experimental Pharmacology (…
  • Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), c/ Juan de la Cierva 3, 28006 Madrid, Spain.
  • Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), c/ Juan de la Cierva 3, 28006 Madrid, Spain; High Performance Research Group in Experimental Pharmacology (PHARMAKOM-URJC), Univ…
  • Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. Atenas s/n 28922 Alcorcón, Madrid, Spain; Unidad Asociada I+D+i al Instituto de Química Médica (IQM), Co…

Förderung

  • H2020 European Research Council
  • Community of Madrid Department of Education Science and Universities
  • State Agency of Research
  • European Social Fund Plus
  • Consejo Superior de Investigaciones Científicas
  • Health Sciences, University of Arizona
  • Comunidad de Madrid
  • Ministerio de Ciencia e Innovación

Zitieren

APA

González-Ruiz, A., Flaj, S., Fernández-Cabello, V., Quesada, E., López-Miranda, V., & Herradón, E. (2026). TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats. International Immunopharmacology, 183, 116884. https://doi.org/10.1016/j.intimp.2026.116884

Vancouver

González-Ruiz A, Flaj S, Fernández-Cabello V, Quesada E, López-Miranda V, Herradón E. TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats. International Immunopharmacology. 2026;183:116884. doi:10.1016/j.intimp.2026.116884

BibTeX
@article{GonzlezRuiz2026,
  author = {González-Ruiz, Antonio and Flaj, Silvia and Fernández-Cabello, Víctor and Quesada, Ernesto and López-Miranda, Visitación and Herradón, Esperanza},
  title = {TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {183},
  pages = {116884},
  doi = {10.1016/j.intimp.2026.116884}
}
Kostenlos starten →